DOI: 10.36347/sjet.2018.v06i10.004

Pages: 306-311

The inclusion complex of imazethapyr with 2-hydroxypropyl-β-Cyclodextrin (HPCD), was prepared in an oscillator and its solubility was enhanced. The inclusion complexes formed were characterized by Fourier Transform Infrared Spectroscopy (FTIR), 1H nuclear magnetic resonance (1H NMR), X-ray diffraction (XRD), and Differential Scanning Calorimetry (DSC) and Thermogravimetric Analysis (TG) methods. The results indicated that the formation of a new compound, which has higher thermal stability and solubility. In the later bioactivity tests, there is still bioactivity in the new inclusion complex.